European Wax Center Insider Grants: 125K RSUs, 465K Options Disclosed

Rhea-AI Filing Summary

Angela Marie Jaskolski, Chief Operating Officer of European Wax Center, Inc. (EWCZ), reported equity awards on 08/18/2025. The filing shows 125,000 restricted stock units granted that vest in four equal annual installments beginning 08/18/2026, subject to continued employment. The filing also reports three option grants totaling 465,000 employee stock options: 195,000 at a $4.66 exercise price, 135,000 at $9.00 and 135,000 at $12.00. These options were granted 08/18/2025 and will become 100% vested and exercisable on 08/18/2029, subject to continued employment, with an expiration date of 08/18/2035. Following the reported transactions, the reporting person beneficially owns 125,000 Class A shares directly and the listed options convertible into 465,000 shares.

Positive

• Retention-focused structure: RSUs vest over four years and options vest after a multi-year period, aligning executive incentives with long-term performance.
• Clear vesting terms: Filing specifies vesting commencement dates and 100% vesting date for options, providing transparency on timing.

Negative

• Potential dilution: Combined 465,000 options and 125,000 RSUs could dilute shareholders if exercised or vested; materiality cannot be assessed without total shares outstanding.
• No performance linkage disclosed: Awards are time‑based only in the filing, so investor assurance of pay‑for‑performance is limited.

Insights

Financial Analyst

TL;DR: Routine executive equity awards align incentives; dilution and timing matter for valuation.

The grants to the COO are standard compensation tools: time‑based restricted stock units and strike‑priced options with multi‑year cliff vesting. The aggregate option pool of 465,000 shares and 125,000 RSUs represent potential future dilution if exercised or vested; materiality depends on EWCZ's outstanding share count (not provided). The staggered exercise prices ($4.66, $9.00, $12.00) indicate multi‑tranche targeting of different performance/retention horizons. For analysts, key implications are dilution schedule, potential accounting expense for share‑based compensation, and retention signaling by management.

Corporate Governance Expert

TL;DR: Compensation structure emphasizes retention through time‑based vesting; requires disclosure context to assess governance impact.

The awards' four‑year RSU vesting and a 100% cliff for options to vest in 2029 reflect a strong retention focus. This is governance‑typical but the filing lacks information on the grant rationale, whether linked to performance metrics, and the grant approval process. Without board approval details or percentage of total equity these awards represent, it is difficult to judge whether they are routine or unusually large relative to peer practices.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

JASKOLSKI ANGELA MARIE

(Last) (First) (Middle)

5830 GRANITE PARKWAY, 3RD FLOOR

(Street)

PLANO TX 75024

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
European Wax Center, Inc. [ EWCZ ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Operating Officer

3. Date of Earliest Transaction (Month/Day/Year)
08/18/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A Common Stock	08/18/2025		A		125,000(1)	A	$0	125,000	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Employee Stock Option (right to buy)	$4.66	08/18/2025		A		195,000		08/18/2029(2)	08/18/2035	Class A Common Stock	195,000	$0	195,000	D
Employee Stock Option (right to buy)	$9	08/18/2025		A		135,000		08/18/2029(2)	08/18/2035	Class A Common Stock	135,000	$0	135,000	D
Employee Stock Option (right to buy)	$12	08/18/2025		A		135,000		08/18/2029(2)	08/18/2035	Class A Common Stock	135,000	$0	135,000	D

Explanation of Responses:

1. Represents restricted stock units that vest in four equal annual installments beginning on August 18, 2026, subject to the reporting person's continued employment on the applicable vesting date.

2. These options will become 100% vested and exercisable on August 18, 2029, subject to the reporting person's continued employment on the applicable vesting date.

	/s/ Gavin M. O'Connor, attorney-in-fact	08/19/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did EWCZ insider Angela Jaskolski receive on 08/18/2025?

The filing reports 125,000 restricted stock units and 465,000 employee stock options granted on 08/18/2025.

When do the RSUs and options vest for EWCZ's COO?

The RSUs vest in four equal annual installments beginning 08/18/2026. The options become 100% vested and exercisable on 08/18/2029 (expiration 08/18/2035), subject to continued employment.

What are the exercise prices for the options disclosed in the Form 4?

The options have exercise prices of $4.66, $9.00, and $12.00 for the respective tranches.

How many Class A shares does the reporting person own after the transaction?

The filing reports 125,000 Class A common shares beneficially owned following the reported transactions.

Are these grants subject to employment conditions?

Yes, the RSUs and options vesting are explicitly subject to the reporting person's continued employment on each applicable vesting date.